AEMD Aethlon Medical, Inc. - Common Stock

NASDAQ · Health Care · View on SEC EDGAR ↗
$2.87
Price · Aug 19, 2026
Fundamentals as of Aug 13, 2026

About Aethlon Medical, Inc. - Common Stock Company overview from Wikipedia

AEMD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$2.87
Market Cap
$901.5K
P/E (TTM)
-0.1
EPS (TTM)
$-10.61
Revenue (TTM)
$0
Div Yield
ROE
-134.5%
Debt/Equity
52W Range
$1 – $27

AEMD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $0
4-point trend, -100.0%
2021-03-31 2024-03-31
EPS $-10.61
5-point trend, -1394.4%
2022-03-31 2026-03-31
Free Cash Flow $-7M
5-point trend, -2.6%
2021-03-31 2026-03-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
AEMD
Peer Median
P/E (TTM)
5-point trend, +100.0%
-0.1
27.5
P/S (TTM)
5-point trend, -99.3%
52.7
3.4
P/B
5-point trend, -100.0%
0.2
0.6
Price / FCF
5-point trend, +100.0%
-0.1

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
AEMD
Peer Median
ROA
5-point trend, -54.6%
-104.5%
-102.7%
ROE
5-point trend, -60.7%
-134.5%
-142.6%
ROIC
-149.3%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
AEMD
Peer Median
Current Ratio
5-point trend, -48.9%
3.8
2.1
Quick Ratio
5-point trend, -52.3%
3.5

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
AEMD
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
AEMD
Peer Median
EPS (Diluted)
5-point trend, -1394.4%
$-10.61

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
AEMD
Peer Median

AEMD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

SELL 7 analysts
  • Strong Buy 0 0.0%
  • Buy 0 0.0%
  • Hold 4 57.1%
  • Sell 1 14.3%
  • Strong Sell 2 28.6%

12-Month Price Target

2 analysts · 2026-08-17
Median target $16.25 +466.2%
Mean target $16.25 +466.2%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-12.0%
Period EPS Actual EPS Est Surprise
March 31, 2027 $-4.02 $-0.80
June 30, 2026 $-4.02 $-0.80 -3.2%
March 31, 2026 $-1.49 $-2.06 0.56%
Dec. 31, 2025 $-2.45 $-2.47 0.02%
Sept. 30, 2025 $-3.74 $-3.74 -0.00%
June 30, 2025 $-8.50 $-8.77 0.27%
March 31, 2025 $-79.70 $-10.30 -69.4%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
AEMD $3M -0.2 -134.5%
TNON
IVF -0.0 4.7%
VBIO
ABT $250.18B 33.7 5.7% 14.7% 13.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16
Annual Income Statement data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
Revenue 10-point trend, -100.0% · · $0 $574.2K $294.2K $659.1K $650.2K $229.6K $149.6K $392.1K $886.6K $762.4K
R&D Expense 12-point trend, +86.0% $2M $2M $3M $3M $2M $2M $927.0K $896.0K $586.0K $673.0K $782.0K $1M
SG&A Expense 12-point trend, +197.3% $3M $3M $4M $4M $3M $2M $2M $953.5K $792.6K $849.5K $929.0K $907.1K
Operating Expenses 12-point trend, +53.4% $7M $9M $13M $12M $11M $9M $7M $6M $5M $6M $5M $5M
Operating Income 12-point trend, -82.7% $-7M $-9M $-13M $-12M $-10M $-8M $-6M $-6M $-5M $-6M $-4M $-4M
Interest Expense 3-point trend, -96.6% · $10.1K · · · · · · · · $125.6K $298.0K
Interest Income 2-point trend, -47.5% $156.5K $298.1K · · · · · · · · · ·
Other Non-op 5-point trend, +164.5% $142.2K $-4M · · · $-1.6K $-450.1K $-220.5K · · · ·
Pretax Income 2-point trend, +46.6% $-7M $-13M · · · · · · · · · ·
Income Tax Flat — no change across 12 periods $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income 12-point trend, -5.2% $-7M $-13M $-12M $-12M $-10M $-8M $-6M $-6M $-6M $-7M $-5M $-7M
EPS (Basic) 5-point trend, -1394.4% $-10.61 $-85.77 $-38.87 $-5.86 $-0.71 · · · · · · ·
EPS (Diluted) 5-point trend, -1394.4% $-10.61 $-85.77 $-38.87 $-5.86 $-0.71 · · · · · · ·
Shares (Basic) 5-point trend, -95.4% 673,945 156,085 314,097 2,053,744 14,756,967 · · · · · · ·
Shares (Diluted) 5-point trend, -95.4% 673,945 156,085 314,097 2,053,744 14,756,967 · · · · · · ·
EBITDA 11-point trend, -76.2% $-7M $-9M · $-12M $-10M $-8M $-6M $-6M $-5M $-6M $-4M $-4M
Balance Sheet 23
Annual Balance Sheet data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
Cash & Equivalents 12-point trend, +487.5% $5M $6M $5M $15M $17M $10M $10M $4M $7M $2M $2M $855.6K
Receivables 9-point trend, -100.0% · · · $0 $128.0K $149.1K $206.7K $0 $74.8K $0 $199.5K $193.3K
Prepaid Expense 12-point trend, +354.1% $332.1K $448.5K $506.0K $557.6K $956.6K $341.1K $229.6K $210.0K $181.4K $37.6K $53.3K $73.1K
Current Assets 12-point trend, +362.4% $6M $6M $6M $15M $18M $10M $10M $4M $7M $2M $2M $1M
PP&E (Net) 12-point trend, +536.1% $356.8K $676.2K $1M $1M $441.2K $161.0K $140.5K $6.0K $27.6K $29.2K $36.0K $56.1K
PP&E (Gross) 12-point trend, +327.0% $2M $2M $2M $990.0K $813.4K $585.9K $526.0K $374.4K $376.9K $352.1K $394.4K $385.1K
Accum. Depreciation 12-point trend, +291.3% $1M $978.9K $990.5K $734.2K $493.9K $424.9K $385.5K $368.3K $349.4K $322.9K $358.4K $329.0K
Intangibles 12-point trend, -100.0% $0 $550 $1.1K $1.6K $2.2K $57.0K $57.5K $66.7K $75.8K $85.0K $94.2K $103.3K
Other Non-current Assets 2-point trend, +33.6% · · · · · · · · · · $22.4K $16.8K
Total Assets 12-point trend, +358.7% $6M $7M $8M $18M $19M $11M $10M $4M $7M $2M $3M $1M
Accounts Payable 12-point trend, +12.4% $384.6K $534.5K $777.9K $432.9K $500.0K $337.7K $285.0K $131.9K $124.5K $484.4K $244.8K $342.1K
Short-term Debt · · · · · · · · · · · $0
Current Liabilities 12-point trend, +152.1% $1M $2M $2M $2M $2M $1M $1M $2M $478.0K $611.8K $526.6K $574.0K
Capital Leases 8-point trend, +0.00 $0 $336.7K $649.8K $939.6K $602.5K $0 $42.5K $0 · · · ·
Total Liabilities 12-point trend, +98.4% $1M $2M $2M $2M $2M $1M $1M $2M $1M $1M $1M $729.2K
Total Debt · · · · · · · · · · · $0
Common Stock 12-point trend, -95.3% $314 $259 $329 $2.3K $15.4K $12.2K $9.4K $1.3K $17.7K $8.8K $7.6K $6.7K
Paid-in Capital 12-point trend, +118.9% $180M $173M $160M $157M $147M $129M $121M $108M $106M $94M $88M $82M
Retained Earnings 12-point trend, -114.5% $-175M $-168M $-155M $-142M $-130M $-120M $-112M $-106M $-99M $-94M $-87M $-82M
AOCI 5-point trend, -32703.00 $-32.7K $-17.1K $-6.9K $-6.1K $0 · · · · · · ·
Stockholders' Equity 12-point trend, +693.9% $5M $5M $6M $15M $17M $9M $9M $2M $6M $676.4K $2M $615.5K
Liabilities + Equity 12-point trend, +358.7% $6M $7M $8M $18M $19M $11M $10M $4M $7M $2M $3M $1M
Shares Outstanding 12-point trend, -95.3% 314,100 201,074 328,728 2,299,259 15,419,163 15,419,163 9,366,873 1,266,979 17,739,511 8,797,086 7,622,393 6,657,046
Cash Flow 12
Annual Cash Flow data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
D&A 12-point trend, +766.5% $323.7K $339.6K $359.1K $240.9K $123.7K $39.9K $26.4K $30.7K $35.7K $32.4K $38.5K $37.4K
Stock-based Comp 12-point trend, -33.1% $278.5K $415.2K $1M $1M $750.6K $779.4K $844.0K $1M $1M $2M $202.8K $416.5K
Amort. of Intangibles 12-point trend, -93.9% $550 $550 $550 $550 $54.8K $550 $9.2K $9.2K $9.2K $9.2K $9.0K $9.0K
Other Non-cash 11-point trend, -134.7% $-449.1K $5M · $231.9K $-225.4K $302.4K $306.0K $551.6K $472.5K $2M $301.7K $1M
Operating Cash Flow 12-point trend, -38.6% $-7M $-8M $-10M $-11M $-10M $-7M $-5M $-4M $-4M $-4M $-4M $-5M
CapEx 12-point trend, +3704.00 $3.7K $0 $250.9K $943.1K $349.2K $59.9K $151.7K $0 $24.8K $16.4K $9.3K $0
Investing Cash Flow 12-point trend, -3704.00 $-3.7K $0 $-250.9K $-943.1K $-349.2K $-59.9K $-151.7K $0 $-24.8K $-16.4K $-9.3K $0
Stock Issued 6-point trend, +44.9% $7M $5M $1M $9M · · · · · · $6M $5M
Net Stock Activity 4-point trend, +44.9% $7M $4M · · · · · · · · $6M $5M
Financing Cash Flow 12-point trend, +40.1% $7M $8M $1M $9M $17M $7M $11M $1M $9M $3M $6M $5M
Net Change in Cash 5-point trend, -106.5% $-473.7K $69.6K $-9M $-3M $7M · · · · · · ·
Free Cash Flow 11-point trend, -38.7% $-7M $-8M · $-11M $-10M $-7M $-5M $-4M $-4M $-4M $-4M $-5M
Profitability 6
Annual Profitability data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
Operating Margin 9-point trend, -295.6% · · · -2072.1% -3542.5% -1197.1% -912.0% -2612.5% -3228.8% -1555.4% -494.6% -523.7%
Net Margin 9-point trend, -135.0% · · · -2094.9% -3540.9% -1196.6% -980.3% -2697.8% -3795.9% -1855.8% -549.6% -891.5%
EBITDA Margin 9-point trend, -291.3% · · · -2030.1% -3500.5% -1191.0% -908.0% -2599.2% -3205.0% -1547.2% -490.2% -518.8%
ROA 11-point trend, +65.1% -104.5% -171.6% · -65.1% -46.0% -67.6% -84.6% -136.5% -86.7% -578.4% -158.5% -299.6%
ROE 11-point trend, -241.8% -134.5% -283.1% · -74.4% -78.4% -83.7% -107.7% -144.8% -166.8% -652.8% -449.4% 94.8%
ROIC -149.3% · · · · · · · · · · ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
Current Ratio 11-point trend, +83.5% 3.8 3.1 · 10.0 10.0 7.5 9.4 2.2 15.1 2.6 4.6 2.1
Quick Ratio 11-point trend, +90.1% 3.5 2.9 · 9.7 9.4 7.3 9.2 2.1 14.7 2.5 4.4 1.8
Debt / Equity · · · · · · · · · · · 0.0
Interest Coverage 2-point trend, -7998.2% · -924.1 · · · · · · · · · -11.4
Efficiency 2
Annual Efficiency data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
Asset Turnover 9-point trend, -90.7% · · · 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.3 0.3
Receivables Turnover 9-point trend, +69.8% · · · 9.0 2.1 3.7 6.3 6.1 4.0 3.9 4.5 5.3
Per Share 5
Annual Per Share data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
Book Value / Share 11-point trend, +3263.7% $3.11 $2.55 · $0.66 $1.11 $0.78 $1.00 $0.13 $0.35 $0.08 $0.20 $0.09
Revenue / Share · · · $0.03 · · · · · · · ·
Cash Flow / Share 3-point trend, -1930.1% $-10.38 $-4.90 · $-0.51 · · · · · · · ·
Cash / Share 11-point trend, +2390.8% $3.20 $2.74 · $0.63 $1.11 $0.81 $1.03 $0.20 $0.39 $0.18 $0.28 $0.13
EPS (TTM) 5-point trend, -1394.4% $-10.61 $-8.58 $-38.87 $-5.86 $-0.71 · · · · · · ·
Growth Rates 1
Annual Growth Rates data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
Revenue YoY 2-point trend, +272.0% · · · 95.2% -55.4% · · · · · · ·
Valuation (TTM) 14
Annual Valuation (TTM) data for AEMD
Metric Trend 202620252024202320222021202020192018201720162015
Revenue TTM 12-point trend, -97.8% $17.1K $17.1K $0 $574.2K $294.2K $659.1K $650.2K $229.6K $149.6K $392.1K $886.6K $762.4K
Net Income TTM 12-point trend, -5.2% $-7M $-13M $-12M $-12M $-10M $-8M $-6M $-6M $-6M $-7M $-5M $-7M
Market Cap 11-point trend, -100.0% $3M $58M · $6.99B $18.01B $19.73B $11.39B $216.65B $253.32B $345.20B $490.27B $918.67B
Enterprise Value · · · · · · · · · · · $918.67B
P/E 5-point trend, +100.0% -0.2 -3.4 -3.5 -51.9 -1645.1 · · · · · · ·
P/S 11-point trend, -100.0% 200.9 3383.1 · 12172.0 61222.7 29938.5 17518.8 943488.2 1693034.0 880442.3 552997.7 1204947.4
P/B 11-point trend, -100.0% 0.7 11.3 · 464.0 1051.2 2092.4 1210.5 89335.6 41297.5 510361.3 315750.6 1492684.0
P / Tangible Book 6-point trend, -100.0% 0.7 11.3 61.3 464.0 1060.1 2105.1 · · · · · ·
P / Cash Flow 11-point trend, +100.0% -0.5 -7.6 · -665.4 -1843.9 -2916.9 -2191.5 -50460.4 -64776.5 -98461.9 -113245.0 -181936.4
P / FCF 11-point trend, +100.0% -0.5 -7.6 · -610.5 -1780.2 -2891.3 -2129.4 -50460.4 -64367.9 -98002.6 -113002.1 -181936.4
EV / EBITDA · · · · · · · · · · · -232251.6
EV / FCF · · · · · · · · · · · -181936.3
EV / Revenue · · · · · · · · · · · 1204946.2
Earnings Yield 5-point trend, -807350.0% -484.5% -29.8% -28.9% -1.9% -0.06% · · · · · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2026-03-312025-03-312024-03-312023-03-312022-03-31
Revenue $0$574.2K$294.2K
Operating Margin % -2072.1%-3542.5%
Net Income $-7M$-13M$-12M$-12M$-10M
Diluted EPS $-10.61$-85.77$-38.87$-5.86$-0.71
Balance Sheet
2026-03-312025-03-312024-03-312023-03-312022-03-31
Current Ratio 3.83.110.010.0
Quick Ratio 3.52.99.79.4
Cash Flow
2026-03-312025-03-312024-03-312023-03-312022-03-31
Free Cash Flow $-7M$-8M$-11M$-10M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 19 filers · $113K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
9 (+3 vs prior Q) 2 (0 vs prior Q) 4 (+4 vs prior Q) 1 (+1 vs prior Q) +168K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
CITADEL ADVISORS LLC $35,387 42,977 31.39% Shares
Shay Capital LLC $25,585 31,072 22.70% Shares
Ikarian Capital, LLC $11,827 14,364 10.49% Shares
JANE STREET GROUP, LLC $8,864 10,765 7.86% Shares
Scientech Research LLC $8,278 10,054 7.34% Shares
GEODE CAPITAL MANAGEMENT, LLC $8,086 9,821 7.17% Shares
UBS Group AG $7,305 8,876 6.48% Shares
Tower Research Capital LLC (TRC) $5,213 6,331 4.62% Shares
MORGAN STANLEY $2,035 2,472 1.81% Shares
HRT FINANCIAL LP $59 72,743 0.05% Shares
Virtu Financial LLC $23 27,815 0.02% Shares
JONES FINANCIAL COMPANIES LLLP $15 17 0.01% Shares
MERCER GLOBAL ADVISORS INC /ADV $13 16 0.01% Shares
Integrated Wealth Concepts LLC $12 15 0.01% Shares
GROUP ONE TRADING LLC $12 14 0.01% Shares
BlackRock, Inc. $8 10 0.01% Shares
WELLS FARGO & COMPANY/MN $2 3 0.00% Shares
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $2 2 0.00% Shares
DANSKE BANK A/S $1 1 0.00% Shares

Company insiders 17 insiders · 9 officers · 12 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Charles J Fisher JR Chief Executive Officer Feb. 10, 2022 A 19,569 0 0 $0
Timothy C Rodell JR Chief Executive Officer April 3, 2020 A 0 0 $0
James A Joyce Chairman, CEO, Secretary Aug. 24, 2016 G 2,000 0 0 $0
James B Frakes CFO & Sr. VP ? Finance Feb. 10, 2022 A 2,483 0 0 $0
Rodney S Kenley President Aug. 9, 2016 A 0 0 $0
Lee D Arnold Chief Scientific Officer Feb. 1, 2023 A 0 0 $0
Steven P Larosa Chief Medical Officer Feb. 10, 2022 A 0 0 $0
Guy F. Cipriani Sr. V.P., Chief Bus. Officer Feb. 10, 2022 A 17,901 0 0 $0
Richard Tullis VP, CHIEF SCIENCE OFFICER June 6, 2014 A 526,750 0 0 $0
Nicolas Gikakis Director June 30, 2026 F 20,663 0 0 $0
Chetan Shah Director June 30, 2026 F 20,840 0 0 $0
Edward G Broenniman Director June 30, 2026 F 22,363 0 0 $0
Angela Rossetti Director April 28, 2023 A 167,649 0 0 $0
Sabrina Martucci Johnson Director March 31, 2022 F 33,642 0 0 $0
Franklyn S Barry JR Director Aug. 9, 2016 A 106,593 0 0 $0
Phillip A Ward March 14, 2014 A 0 0 $0
Calvin M Leung Feb. 23, 2005 A 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 5 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Ellen R. Weiner Family Revocable Trust Feb. 18, 2015 Initial filing SEC
Undisclosed reporting person Dec. 16, 2005 Initial filing SEC
Undisclosed reporting person Dec. 16, 2005 Initial filing SEC
Undisclosed reporting person Nov. 23, 2005 Initial filing Passive investment SEC
Undisclosed reporting person Nov. 23, 2005 Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.